Stockscreener 앱 받기
7.42
1.07%
-0.08
시간 외 거래:
7.89
0.47
+6.33%
전일 마감가:
$7.50
열려 있는:
$7.5
하루 거래량:
181.85K
Relative Volume:
2.42
시가총액:
$271.45M
수익:
$4.71M
순이익/손실:
$-46.77M
주가수익비율:
-4.4188
EPS:
-1.6792
순현금흐름:
$-60.34M
1주 성능:
+1.64%
1개월 성능:
-7.02%
6개월 성능:
-30.30%
1년 성능:
-11.03%
1일 변동 폭
$7.353
$7.6222
1주일 범위
$7.22
$7.65
52주 변동 폭
$5.55
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
NYXH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
7.42 | 271.45M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-31 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2022-04-21 | 개시 | Oppenheimer | Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2021-12-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Nyxoah Sa 주식(NYXH)의 최신 뉴스
FDA Approves Nyxoah's Revolutionary Sleep Apnea Device While Inspire Launches Patent Battle - Stock Titan
Statistical indicators supporting Nyxoah SA’s strengthMarket Ready Picks with Technical Support - Newser
What recovery options are there for Nyxoah SAWeekly High Conviction Trade Setup Analysis - Newser
What are the future prospects of Nyxoah SATrade Picks with 3x Upside - thegnnews.com
Smart tools for monitoring Nyxoah SA’s price actionSwing Entry Insight With Forecast Accuracy - Newser
Real time social sentiment graph for Nyxoah SAFree Low Risk Picks for Daily Trading - Newser
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea - TradingView
FDA Approval: New Genio Sleep Apnea Device Shows 71% Success Rate in Clinical Trials - Stock Titan
How Nyxoah SA stock performs during market volatilityTechnical Reversal Setup with Risk Limits - Newser
When is the best time to buy Nyxoah SA stockFree Opportunity Map for Daily Stock Trading - Newser
Is Nyxoah SA forming a reversal patternHigh Reward Picks with Tight Risk Control - Newser
What drives Nyxoah SA stock priceOverwhelming financial success - Jammu Links News
Is it the right time to buy Nyxoah SA stockStay ahead with daily market updates - Jammu Links News
How does Nyxoah SA generate profit in a changing economyFree Stock Market Query - Jammu Links News
Does Nyxoah SA stock perform well during market downturnsHigh-profit stock alerts - Jammu Links News
What are the latest earnings results for Nyxoah SAFree Daily Trading Room Entry - Jammu Links News
How volatile is Nyxoah SA stock compared to the marketAchieve breakthrough performance with smart picks - Jammu Links News
What is the risk reward ratio of investing in Nyxoah SA stockFree Predictions - Jammu Links News
What markets is Nyxoah SA expanding into Is HTOOW stock a good long term investment optionExplosive returns - Jammu Links News
When is Nyxoah SA stock expected to show significant growthStrongest growth potential - Jammu Links News
Is Nyxoah SA stock overvalued or undervaluedMassive stock growth - Jammu Links News
What are Nyxoah SA company’s key revenue driversMarket-crushing profits - Jammu Links News
How strong is Nyxoah SA company’s balance sheetFree Investment Risk Control - Jammu Links News
Should I hold or sell Nyxoah SA stock in 2025Fastest-growing stock picks - Jammu Links News
What catalysts could drive Nyxoah SA stock higher in 2025Stock Market Forecasts For 2025 - Jammu Links News
Published on: 2025-08-01 01:40:43 - Newser
Nyxoah SA stock daily chart insightsWeekly Portfolio Update with ROI Focus - Newser
New Product Launches: Will They Boost Nyxoah SA Stock in 2025Stock Forecast Tools for Retail Traders - Newser
Moving Average Trends for Nyxoah SA Stock: What They IndicateReal Time Stock Movement and Alerts - Newser
Nyxoah Announces Q2 2025 Financial Results Release and Conference Call on August 18, 2025 - AInvest
Is Nyxoah SA Stock a Good Fit for Conservative InvestorsTarget Return Focused Trade Insights Shared - metal.it
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 - The Manila Times
Nyxoah Announces Major Share Structure Update: 37.4M Voting Rights and 2.8M Subscription Rights - Stock Titan
Nyxoah Earnings: Sleep Apnea Tech Leader Sets Q2 2025 Financial Report Date - Stock Titan
Pivotal Trial Results Released for Bilateral Hypoglossal Nerve Stimulator for OSA - Sleep Review
Nyxoah stock rises on positive DREAM study data publication By Investing.com - Investing.com Australia
Trapped Investors in Nyxoah SA Await Breakout SignalWeekly Stock Watch With Growth Focus Expanded - metal.it
Nyxoah stock rises on positive DREAM study data publication - Investing.com
Nyxoah Sa (NYXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
자본화:
|
볼륨(24시간):